VSOT-STUDY OF SOME CHARACTERISTICS OF BK VIRUS INFECTION IN KIDNEY RECIPIENTS

Quý Kiên Trương1, , Quân Vũ Ngô1, Thị Thu Hằng Tống1, Xuân Anh Nguyễn1, Văn Tuấn Nguyễn1, Hồng Xinh Trần1, Quốc Toản Phạm2, Việt Thắng Lê2
1 Bệnh viện Trung ương Quân đội 108
2 Bệnh viện Quân y 103, Học viện Quân y

Main Article Content

Abstract

Objectives: To investigate some characteristics of BKV infection and analyze relations between infection with some clinical and subclinical features in patients after kidney transplant. Subjects and methods: 360 post-kidney transplant patients were treated and monitored at Military Hospital 103 and 108 Military Central Hospital, from October 2020 to June 2024. Patients had pre-transplant data collected, had clinical examinations, performed routine tests, measured BK virus load in blood and urine at the time of the study, and performed kidney allograft biopsies as indicated. Results: The proportion of patients with BKV infection positive was 56.7%. The rate of BKV infection was significantly positive at 41.3%. BKVN rate is 3.1%. BKV load in blood had a moderate positive correlation with BKV load in urine, r = 0.524, p < 0.001. BKV-infected group had lower mean GFR and hemoglobin than BKV-uninfected group, p < 0.05. The BKVN group had statistically significantly lower mean GFR and hemoglobin, longer post-transplant time, higher rate of positive proteinuria, and higher rate of patients receiving Tac than the BKV-positive group without BKVN. There was a negative correlation between BKV load in blood and urine with GFR, r = -0.263 and r = -0.147, respectively, p < 0.05. Conclusions: The rate of BKV infection in patients after kidney transplant is relatively high. BKV infection causes reduced kidney graft function. Long-time post-transplant and use of Tacrolimus increase the rate of BKVN.

Article Details

References

1. Hirsch HH, Randhawa PS, Practice AST. Infectious diseases community of bk polyomavirus in solid organ transplantation-guidelines from the American society of transplantation infectious diseases community of practice. Clin Transplant. 2019; 33(9):e13528.
2. Kasiske BL, Zeier MG, Chapman J R, et al. (2010). KDIGO clinical practice guideline for the care of kidney transplant recipients: A summary. Kidney Int. 2010; 77(4):299-311.
3. Funahashi Y. BK Virus-associated nephropathy after renal transplantation. Pathogens. 2021; 10(2).
4. Ertugrul G, Yanaral T. BK virus in kidney transplantation: A single center experiences. Arch Organ Transplant. 2019; 4(1):10-13.
5. Yoon SH, Cho JH, Jung HY, et al. Clinical impact of BK virus surveillance on outcomes in kidney transplant recipients. Transplant Proc. 2015; 47(3):660-665.
6. Hsieh MC, Hung CW, Chiou HL, et al. Effect of a BK viruria reaction detected by qualitative polymerase chain reaction on the renal function of kidney transplant recipients. Mol Med Rep. 2013; 7(4):1319-1323.
7. Gras J, Le Flecher A, Dupont A, et al. Characteristics, risk factors and outcome of BKV nephropathy in kidney transplant recipients: A case-control study. BMC Infect Dis. 2023; 23(1):74.
8. Fallatah N. Immune responses to BK polyomavirus in healthy donors and renal transplant recipients. The University of Liverpool (United Kingdom). 2021.
9. Li P, Cheng D, Wen J, et al. Risk factors for BK virus infection in living-donor renal transplant recipients: A single-center study from China. Ren Fail. 2018; 40(1):442-446.
10. Gately Ryan, Milanzi Elasma, Lim Wai, et al. Incidence, risk factors, and outcomes of kidney transplant recipients with BK polyomavirus-associated nephropathy. Kidney International Reports. 2023; 8(3): 531-543.